Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXVS2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,365
Award facts
- Contract value 100% obligated
- $10,364.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,364.88 to AmerisourceBergen Drug Corp for the supply of Entyvio (vedolizumab) 108 mg/0.68 mL in pre-filled pen form on January 27, 2026. This competitive award, with no set-aside designation, carries a firm fixed price structure and is scheduled for completion by February 18, 2026. The product will be delivered to the company's location in Conshohocken, Pennsylvania. Entyvio is a biologic immunosuppressant used to treat inflammatory bowel diseases, and this delivery order represents a single task order executed under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government.
This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. AmerisourceBergen, as a major pharmaceutical distributor, continues to supply critical medical commodities to the Defense Health Agency and other federal healthcare systems through this flexible contracting mechanism, demonstrating the company's established capability to meet federal procurement requirements for essential medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FXVS2?
SPE2DR26FXVS2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FXVS2 worth?
The government has obligated $10,365 on SPE2DR26FXVS2.
Is contract SPE2DR26FXVS2 an order under another contract?
Yes. SPE2DR26FXVS2 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVS2 competed?
The extent of competition for SPE2DR26FXVS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award